164 related articles for article (PubMed ID: 12191634)
1. DNA methylation changes in leukaemia.
Melki JR; Clark SJ
Semin Cancer Biol; 2002 Oct; 12(5):347-57. PubMed ID: 12191634
[TBL] [Abstract][Full Text] [Related]
2. Expression analysis of the epigenetic methyltransferases and methyl-CpG binding protein families in the normal B-cell and B-cell chronic lymphocytic leukemia (CLL).
Kn H; Bassal S; Tikellis C; El-Osta A
Cancer Biol Ther; 2004 Oct; 3(10):989-94. PubMed ID: 15467427
[TBL] [Abstract][Full Text] [Related]
3. Multifaceted Roles of DNA Methylation in Neoplastic Transformation, from Tumor Suppressors to EMT and Metastasis.
Casalino L; Verde P
Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32806509
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation in breast cancer.
Yang X; Yan L; Davidson NE
Endocr Relat Cancer; 2001 Jun; 8(2):115-27. PubMed ID: 11446343
[TBL] [Abstract][Full Text] [Related]
5. Alterations of DNA methylation in hematologic malignancies.
Rush LJ; Plass C
Cancer Lett; 2002 Nov; 185(1):1-12. PubMed ID: 12142073
[TBL] [Abstract][Full Text] [Related]
6. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
7. Aberrant DNA methylation-induced gene inactivation is associated with the diagnosis and/or therapy of T-cell leukemias.
Kim SY; Shin DY; Kim SM; Lee M; Kim EJ
Leuk Res; 2016 Aug; 47():116-22. PubMed ID: 27318093
[TBL] [Abstract][Full Text] [Related]
8. Methylation profiling of CpG islands in human breast cancer cells.
Huang TH; Perry MR; Laux DE
Hum Mol Genet; 1999 Mar; 8(3):459-70. PubMed ID: 9949205
[TBL] [Abstract][Full Text] [Related]
9. Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells deficient in DNA methyltransferases.
Paz MF; Wei S; Cigudosa JC; Rodriguez-Perales S; Peinado MA; Huang TH; Esteller M
Hum Mol Genet; 2003 Sep; 12(17):2209-19. PubMed ID: 12915469
[TBL] [Abstract][Full Text] [Related]
10. Dormant hypermethylated tumour suppressor genes: questions and answers.
Esteller M
J Pathol; 2005 Jan; 205(2):172-80. PubMed ID: 15643671
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation and developmental genes in lymphomagenesis--more questions than answers?
Kay PH; Spagnolo DV; Taylor J; Ziman M
Leuk Lymphoma; 1997 Jan; 24(3-4):211-20. PubMed ID: 9156651
[TBL] [Abstract][Full Text] [Related]
12. Gene silencing by DNA methylation in haematological malignancies.
Boultwood J; Wainscoat JS
Br J Haematol; 2007 Jul; 138(1):3-11. PubMed ID: 17489980
[TBL] [Abstract][Full Text] [Related]
13. CpG methylation is maintained in human cancer cells lacking DNMT1.
Rhee I; Jair KW; Yen RW; Lengauer C; Herman JG; Kinzler KW; Vogelstein B; Baylin SB; Schuebel KE
Nature; 2000 Apr; 404(6781):1003-7. PubMed ID: 10801130
[TBL] [Abstract][Full Text] [Related]
14. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.
Esteller M
Oncogene; 2002 Aug; 21(35):5427-40. PubMed ID: 12154405
[TBL] [Abstract][Full Text] [Related]
15. Impaired recruitment of the histone methyltransferase DOT1L contributes to the incomplete reactivation of tumor suppressor genes upon DNA demethylation.
Jacinto FV; Ballestar E; Esteller M
Oncogene; 2009 Nov; 28(47):4212-24. PubMed ID: 19734945
[TBL] [Abstract][Full Text] [Related]
16. Promoter methylation status of tumor suppressor genes and inhibition of expression of DNA methyltransferase 1 in non-small cell lung cancer.
Liu B; Song J; Luan J; Sun X; Bai J; Wang H; Li A; Zhang L; Feng X; Du Z
Exp Biol Med (Maywood); 2016 Aug; 241(14):1531-9. PubMed ID: 27190263
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma.
Chaisaingmongkol J; Popanda O; Warta R; Dyckhoff G; Herpel E; Geiselhart L; Claus R; Lasitschka F; Campos B; Oakes CC; Bermejo JL; Herold-Mende C; Plass C; Schmezer P
Oncogene; 2012 Dec; 31(49):5108-16. PubMed ID: 22286769
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation and cancer therapy.
Szyf M
Drug Resist Updat; 2003 Dec; 6(6):341-53. PubMed ID: 14744498
[TBL] [Abstract][Full Text] [Related]
19. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells.
Rhee I; Bachman KE; Park BH; Jair KW; Yen RW; Schuebel KE; Cui H; Feinberg AP; Lengauer C; Kinzler KW; Baylin SB; Vogelstein B
Nature; 2002 Apr; 416(6880):552-6. PubMed ID: 11932749
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of DNA (Cytosine-5)-Methyltransferase 1 (DNMT1) And DNA (Cytosine-5)-Methyltransferase 3A (DNMT3A) Is Associated with Aggressive Behavior and Hypermethylation of Tumor Suppressor Genes in Human Pituitary Adenomas.
Ma HS; Wang EL; Xu WF; Yamada S; Yoshimoto K; Qian ZR; Shi L; Liu LL; Li XH
Med Sci Monit; 2018 Jul; 24():4841-4850. PubMed ID: 30002361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
